Mayne Pharma has launched budesonide capsules in a 3 mg dose in the U.S. Budesonide is a generic alternative to Entocort EC, which is used as a treatment for patients with mild to moderate Crohn’s disease.  “This latest addition to Mayne Pharma’s fast-growing generic portfolio reflects the company’s core strengths in complex drug delivery formulations and technologies,” said Stefan Cross, president, Mayne Pharma USA. “This expertise paves the way to creating more high-quality generic alternat...